Pre-Market Earnings Report for August 1, 2025 : XOM, CVX, LIN, ENB, CL, REGN, GWW, D, IMO, KMB, ARES, CBOE

A diverse group of major companies, including energy giants Exxon Mobil and Chevron, industrial gas producer Linde, and pharmaceutical firm Regeneron, are set to report Q2 2025 earnings on August 1st. While consensus estimates project significant year-over-year EPS declines for the oil majors (over 30%) and Regeneron (nearly 40%), other firms like Linde, Dominion Energy, Ares Management, and Cboe Global Markets are forecast for growth. Despite these mixed immediate outlooks and varied historical performance against estimates, many of these companies, particularly in energy, chemicals, and finance, trade at higher 2025 P/E ratios relative to their industry peers, suggesting analysts and the market anticipate stronger long-term earnings growth for these specific entities.

Analysis

The upcoming Q2 2025 earnings season presents a starkly divergent outlook across key sectors. The energy complex, including Exxon Mobil (XOM) and Chevron (CVX), is bracing for significant year-over-year earnings contractions, with consensus EPS forecasts down 30.37% and 34.90% respectively. Despite these sharp declines, their forward P/E ratios of 17.01 and 21.15 remain substantially above the industry average of 4.10, indicating that the market is pricing in a strong recovery or long-term growth that overshadows near-term cyclical weakness. In contrast, companies like Linde (LIN), Ares Management (ARES), and Cboe Global Markets (CBOE) are expected to report positive EPS growth, with ARES and CBOE leading with projected increases of 12.12% and 12.56%. Their premium valuations relative to their industries are consistent with these growth expectations. Several companies present specific risk profiles: Regeneron (REGN) faces a severe 39.70% forecasted EPS decline and recently missed estimates, signaling significant headwinds. Conversely, Dominion Energy (D) projects robust 25.45% EPS growth, yet its valuation is below its industry peers, likely reflecting investor skepticism following a recent earnings miss. Consumer staples like Colgate-Palmolive (CL) and Kimberly-Clark (KMB) show modest EPS declines and trade at P/E ratios below their industry, suggesting muted market expectations.

Key Decisions for Investors

• Given the steep expected EPS declines at Exxon Mobil and Chevron, investors should scrutinize management guidance for evidence supporting their premium P/E valuations relative to the industry.
• For growth-oriented names like Ares Management and Cboe Global Markets, meeting or exceeding their double-digit growth forecasts is critical to justify their high multiples, making any deviation a key catalyst.
• The combination of a nearly 40% expected EPS drop and a recent earnings miss makes Regeneron a high-risk holding, warranting a review of positions or consideration of hedging strategies ahead of the report.
• Dominion Energy presents a potential value opportunity with its 25.45% projected EPS growth and below-industry P/E, but investors must weigh this against the execution risk highlighted by its recent miss on consensus estimates.